hypertension in acute setting - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased sympathetic nervous system activity leads to vasoconstriction and elevated cardiac output, rapidly raising blood pressure. This acute response is often triggered by stress or pain, and can be compounded by existing cardiovascular conditions.

• Secondary mechanism: Activation of the renin-angiotensin-aldosterone system (RAAS) results in increased angiotensin II levels, causing further vasoconstriction and sodium retention, which exacerbates hypertension. This mechanism is crucial in maintaining elevated blood pressure in the acute setting.

• Key complication: If unaddressed, acute severe hypertension can lead to end-organ damage such as hypertensive encephalopathy or acute heart failure, requiring immediate intervention to prevent morbidity and mortality.

Patient Profile

Demographics:

67-year-old male, retired construction worker

History:

• Key past medical history: Long-standing hypertension, type 2 diabetes mellitus, chronic kidney disease stage 3, previous myocardial infarction, hyperlipidemia

• Current medications: Lisinopril, metformin, atorvastatin, aspirin, furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe headache and shortness of breath

• Key symptoms: Blurred vision, chest pain, nausea, dizziness

• Vital signs: Blood pressure 210/130 mmHg, heart rate 110 bpm, respiratory rate 28 breaths per minute, temperature 98.6°F, oxygen saturation 88% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the intensive care unit, the initial nursing assessment of the patient reveals several critical findings. The patient is diaphoretic, with pallor noted on the face and extremities, indicating possible poor perfusion. Neurological assessment shows the patient is alert but disoriented to time and place, suggesting possible cerebral involvement due to hypertensive encephalopathy. Cardiovascular assessment highlights jugular venous distension and an S3 gallop upon auscultation, raising concerns for acute decompensated heart failure. Peripheral pulses are weak and thready, and there is mild pitting edema noted in the lower extremities. Respiratory examination reveals bilateral crackles on auscultation, with labored breathing and use of accessory muscles, indicating pulmonary congestion secondary to heart failure.

Given the patient's chronic kidney disease, the lab results are crucial for understanding the extent of renal involvement. Serum creatinine is markedly elevated at 2.8 mg/dL (baseline 1.6 mg/dL), and the blood urea nitrogen (BUN) is 46 mg/dL, suggesting an acute on chronic kidney injury potentially due to hypertensive crisis. Electrolyte imbalances are present, with hyperkalemia observed at 5.8 mmol/L, necessitating careful management to prevent cardiac complications. An electrocardiogram shows sinus tachycardia with occasional premature ventricular contractions, and there are concerning signs of left ventricular hypertrophy.

These findings necessitate immediate and aggressive management to prevent further deterioration. The healthcare team must prioritize interventions to lower the patient's blood pressure cautiously to avoid precipitating ischemic events, carefully monitor renal function, and address potential heart failure exacerbation. These considerations require comprehensive clinical reasoning to balance treatment goals and prevent further end-organ damage, guiding the next steps in the patient's care trajectory.

Section 2

Change in Patient Status:

Several hours into the patient's management in the intensive care unit, a change in status is noted. The patient's blood pressure, initially elevated at 220/130 mmHg, has been gradually reduced to 180/110 mmHg following the administration of intravenous antihypertensives. Despite this improvement, the patient becomes increasingly lethargic and is now only oriented to self, raising concerns for worsening cerebral perfusion or a developing cerebrovascular event. Neurologically, there is a new presentation of right-sided weakness and facial droop, suggesting a possible acute ischemic stroke as a complication of the hypertensive crisis. An immediate stat CT scan of the head is ordered to confirm this suspicion and rule out hemorrhagic transformation.

Concurrently, the patient's respiratory status deteriorates, with oxygen saturation dropping to 88% on 4L/min of oxygen via nasal cannula. The use of accessory muscles has intensified, and there is an increase in the frequency of crackles heard upon auscultation, indicating worsening pulmonary edema. Arterial blood gases reveal a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 60 mmHg, pointing towards a mixed respiratory and metabolic acidosis. The healthcare team initiates non-invasive positive pressure ventilation to improve oxygenation and reduce the work of breathing.

In response to these changes, the clinical team must swiftly adjust the management plan. Consideration must be given to the delicate balance of further blood pressure reduction, ensuring cerebral and coronary perfusion is maintained, while also addressing the emergent respiratory distress. The potential stroke requires immediate neurological intervention, and the worsening heart failure symptoms necessitate careful diuresis, keeping in mind the patient's renal impairment. This complex interplay of treatment priorities demands advanced critical thinking to optimize outcomes and prevent further complications. The unfolding scenario calls for a multidisciplinary approach, emphasizing the need for rapid diagnostic clarification and therapeutic adjustments.

Section 3

New Diagnostic Results:

The stat CT scan of the head reveals an acute ischemic stroke in the left middle cerebral artery territory, confirming the clinical suspicion based on the patient's neurological deficits. Fortunately, there is no evidence of hemorrhagic transformation at this stage. The neurology team is immediately consulted to evaluate the suitability of thrombolytic therapy, given the critical time window for such an intervention. Meanwhile, the MRI of the brain is scheduled to provide a more detailed assessment of the ischemic areas and guide further treatment decisions.

Simultaneously, laboratory results return, indicating a serum creatinine level of 2.8 mg/dL, marking a deterioration from the baseline of 1.5 mg/dL, suggestive of acute kidney injury likely exacerbated by both the hypertensive emergency and potential nephrotoxic effects of recent interventions. In light of the pulmonary edema and the need for diuresis, the nephrology team is consulted to weigh in on the feasibility of administering diuretics without worsening renal function. A balance must be struck to manage the fluid overload while preserving renal perfusion.

The arterial blood gas analysis has been repeated following the implementation of non-invasive positive pressure ventilation, showing slight improvement with a pH of 7.35, PaCO2 of 48 mmHg, and PaO2 of 70 mmHg. Despite these positive changes, the patient remains at risk for further respiratory compromise, necessitating continuous monitoring and potential escalation of respiratory support. The clinical team must now integrate these diagnostic findings to refine the treatment strategy, focusing on stabilizing the patient's neurological and respiratory status while mitigating renal and cardiovascular risks. This requires ongoing collaboration across specialties to adapt the management plan in real-time as new data emerge.

Section 4

As the clinical team continues to manage the patient's complex presentation, a change in patient status is noted. The patient begins to exhibit signs of increased intracranial pressure, including a sudden deterioration in consciousness level, characterized by a drop in Glasgow Coma Scale score from 13 to 9. Pupillary assessment reveals anisocoria with a sluggish left pupil, suggesting potential worsening of the cerebral edema. Neurological reassessment prompts an urgent repeat CT scan to evaluate for any new developments such as cerebral edema or hemorrhagic transformation, which could have a significant impact on the ongoing treatment strategy.

Concurrent with the neurological deterioration, the patient’s hemodynamic status becomes increasingly unstable. Blood pressure readings show significant fluctuations, with systolic pressures ranging from 160 mmHg to 220 mmHg despite titration of antihypertensive infusions. This erratic control raises concerns for further cerebrovascular compromise and exacerbation of the ischemic stroke. The cardiology team is consulted to explore additional options for blood pressure management that can safely stabilize the patient’s cardiovascular status without compromising cerebral perfusion.

In this critical juncture, the interdisciplinary team must employ advanced clinical reasoning to prioritize interventions that address the potential for secondary brain injury while minimizing systemic complications. The decision-making process will involve a delicate balancing act of optimizing cerebral perfusion pressure, managing blood pressure fluctuations, and evaluating the potential need for more aggressive interventions such as osmotic therapy or even surgical decompression, should the patient's condition continue to worsen. This scenario underscores the need for continuous re-evaluation and adaptation of the management plan in response to the patient's dynamic clinical status.

Section 5

New Diagnostic Results

As the clinical team awaits the results of the urgent repeat CT scan, laboratory values return, revealing a concerning trend. The patient's serum sodium level has decreased to 126 mEq/L, indicative of hyponatremia. This electrolyte imbalance may be contributing to the cerebral edema and altered mental status. Additionally, recent arterial blood gas analysis shows a pH of 7.32, PaCO2 of 48 mmHg, and HCO3 of 22 mEq/L, suggesting a state of respiratory acidosis, likely due to hypoventilation associated with the decreased level of consciousness.

The CT scan results arrive, confirming a significant increase in cerebral edema with evidence of midline shift, but no new hemorrhagic transformation is noted. This finding suggests that the management of intracranial pressure should be escalated. The team discusses the potential for hypertonic saline administration to address both the hyponatremia and cerebral edema, while also considering the risks and benefits of initiating mannitol therapy to further reduce intracranial pressure. The decision-making process is complicated by the need to maintain adequate cerebral perfusion pressure, particularly in light of the erratic blood pressure readings.

In this high-stakes environment, the team must also evaluate the potential need for surgical intervention, such as decompressive craniectomy, to relieve intracranial pressure. This consideration requires careful deliberation, balancing the risks of surgery against the potential for irreversible neurological damage if conservative measures fail. As these diagnostic insights guide the next steps in the treatment strategy, the interdisciplinary team remains vigilant, ready to pivot their management plan based on the patient's evolving clinical picture.